United States · Platforms & data · MarketBeat

Ligand Pharmaceuticals (NASDAQ:LGND) Issues Earnings Results, Beats Expectations By $0.34 EPS

Published by MarketBeat · United States 1 h ago

Ligand Pharmaceuticals (NASDAQ:LGND - Get Free Report) released its earnings results on Thursday. The biotechnology company reported $2.67 earnings per share (EPS) for the…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Axt projects Q4 non-GAAP EPS of $0.57-$0.59 as backlog moves above $500M

The Motley Fool

Alphabet Sheds $500 Billion in a Single Day Despite Cloud Growth of 103%

MarketWatch

A Starbucks turnaround is brewing — but perhaps not quickly enough for investors

Investing.com

Columbia Financial earnings missed by $0.05, revenue fell short of estimates

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

TheStreet